Teva Pharmaceutical Industries (NYSE:TEVA) Price Target Raised to $30.00
Teva Pharmaceutical Industries (NYSE:TEVA – Free Report) had its price target raised by UBS Group from $28.00 to $30.00 in a research note published on Thursday,Benzinga reports. UBS Group currently ...
Telsey Advisory Group Reaffirms “Outperform” Rating for Deckers Outdoor (NYSE:DECK)
Telsey Advisory Group reissued their outperform rating on shares of Deckers Outdoor (NYSE:DECK – Free Report) in a research ...